Imed Infinity Medical-Limited Partnership
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IMED.TA research report →
Price Chart
About the company
Operating as a research and development partnership, Imed Infinity Medical-Limited Partnership was founded in 2020 and is located in Tel Aviv, Israel. Its central mission involves providing capital for R&D ventures within the medical domain, especially those focused on digital health.
- CEO
- Itay Gal-Or
- IPO
- 2021
- Employees
- 70
- HQ
- Tel Aviv, TA, IL
Get TickerSpark's AI analysis on IMED.TA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $6.16M
- P/E
- 9.75
- PEG
- 0.98
- P/S
- 3.14
- P/B
- 0.33
- EV/EBITDA
- 2.50
- Div Yield
- 0.00%
- Gross Margin
- 93.84%
- Op Margin
- -68.90%
- Net Margin
- -12.22%
- ROE
- -1.09%
- ROIC
- -5.63%
Latest fiscal year · YoY change
- Revenue
- $0-100.0%
- Gross Profit
- $-88,762-316.5%
- Op Income
- $-461,132
- Net Income
- $-147,215+74.4%
- EPS
- $-0.03+77.6%
- OCF Growth
- +42.4%
- FCF Growth
- +42.4%
- 52W High
- $166.00
- 52W Low
- $0.93
- 50D MA
- $70.58
- 200D MA
- $99.31
- Beta
- 0.30
- RSI (14)
- 52
- Avg Volume
- 986
No earnings-call transcripts are available for IMED.TA yet.
- Free Float
- 10.9%
- Shares Outstanding
- 6.83M
- Float Shares
- 740.54K
Our IMED.TA coverage
Recent articles, reports, and earnings notes.
No research on IMED.TA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IMED.TA report →